scispace - formally typeset
M

Monalisa Tiwari

Researcher at Central University of Rajasthan

Publications -  33
Citations -  1736

Monalisa Tiwari is an academic researcher from Central University of Rajasthan. The author has contributed to research in topics: Acinetobacter baumannii & Carbapenem. The author has an hindex of 15, co-authored 33 publications receiving 1024 citations.

Papers
More filters
Journal ArticleDOI

Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action

TL;DR: The molecules considered here might be used to treat biofilm-associated infections after significant structural modifications, thereby investigating its effective delivery in the host and minimum effective concentration must be capable of eradicating biofilm infections with maximum potency without posing any adverse side effects on the host.
Journal ArticleDOI

Mechanism of Anti-bacterial Activity of Zinc Oxide Nanoparticle Against Carbapenem-Resistant Acinetobacter baumannii.

TL;DR: Results demonstrate that ZnO-NP could be developed as alternative therapeutics against A. baumannii, and the proposed mechanism of action of ZNO involves the production of reactive oxygen species, which elevates membrane lipid peroxidation that causes membrane leakage of reducing sugars, DNA, proteins, and reduces cell viability.
Journal ArticleDOI

Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens.

TL;DR: The active compounds of plants that have potent antibacterial activity against many bacteria including carbapenem resistant strain of A. baumannii are reviewed to help researchers involved in the screening of herbal active compounds that might act as a replacement for carbapENem.
Journal ArticleDOI

Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa.

TL;DR: A chimeric vaccine againstMultidrug-resistant Pseudomonas aeruginosa is designed with the help of comparative proteomics and reverse vaccinology approaches and Immunogenic peptides were used to design a multi-epitope vaccine construct.
Journal ArticleDOI

In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii.

TL;DR: This study has identified ZINC01155930 ((4R)-3-(cycloheptoxycarbonyl)-4-(4-etochromen-3-yl)-2-methyl-4,6,7,8-tetrahydroquinolin-5-olate) as a suitable efflux pump inhibitor worthy of further investigation in order to be used for controlling infections caused by Acinetobacter baumannii.